|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cryptocurrency News Articles
SUI Blockchain Captures Headlines with Top 5 DEX Volume, but Technicals Lag
Apr 20, 2025 at 08:04 pm
The SUI blockchain is making headlines after climbing to the fifth position globally in decentralized exchange (DEX) trading volume

The SUI blockchain has entered the fifth position globally in decentralized exchange (DEX) trading volume over the past week, with more than $2.1 billion in transactions reported by TokenTerminal.
This follows a 4.49% rise in volume week-over-week, driven by a spike in token movement and short-term positioning by traders. While placing SUI in the top five chains by DEX volume, it’s still far behind leading blockchains such as Ethereum, Solana, BNB Chain, and Base in terms of total liquidity, ecosystem depth, and institutional adoption.
Relative Strength Index (RSI)
The Relative Strength Index (RSI), which measures buying and selling momentum, has increased from 35.22 to 51.86 over a few days, which indicates that buyers are returning. However, the RSI is still in neutral territory and has yet to reach levels that would indicate a strong bullish trend.
Directional Movement Index (DMI)
The Directional Movement Index (DMI) is sending mixed signals. The Average Directional Index (ADX), which gauges the strength of a trend, has dropped from 14.79 to just 9. An ADX value below 20 generally signals a weak or non-existent trend.
Plus, the +DI indicator is slightly above the -DI, which points to minor bullish control. Overall, the market sentiment remains indecisive.
These indicators suggest that buyers are showing some activity but not enough to establish a firm directional move as sellers still have some influence.
Exponential Moving Averages (EMAs)
There are some encouraging signs as the short-term and long-term exponential moving averages (EMAs) are converging, which hints at a possible golden cross—a bullish pattern where a short-term EMA crosses above a longer-term one.
If this occurs, it could provide the technical confirmation needed to support a stronger rally.
As the price action moves above the Fib level of 0.0, it also marks a key support zone. Breaking below this level could continue to drive the token lower toward the next support at 1.71, signaling further weakness ahead.
Disclaimer:info@kdj.com
The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!
If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.
-
-
- Datavecta Forges Global Community Ecosystem to Power International Growth Through Advanced SEO Strategy
- Sep 30, 2026 at 07:55 pm
- Datavecta is building a global community ecosystem to enhance international growth, leveraging advanced SEO strategies and technology-driven services for a connected intelligent trading future.
-
- Illinois Rolls Out Draft Rules for 0.2% Crypto Transaction Tax, Set for 2027
- Sep 30, 2026 at 12:05 pm
- Illinois unveils draft regulations for its upcoming 0.2% digital asset transaction tax, impacting exchanges, transfers, and custody services starting January 1, 2027. The tax applies to the gross value of transactions, not investment gains.
-
-
- Apeing Leads the Charge: Unveiling the Next 100x Crypto Watchlist and 6 Coins to Eye
- Sep 30, 2026 at 12:03 pm
- Amidst a dynamic crypto market, Apeing's presale momentum, coupled with established players like Solana and TRON, is redefining the 100x crypto narrative, offering both early-stage opportunities and proven network strength.
-
-
- OpenAI Unveils GPT-6.1 Sol and Ultrafast Tier, While AstraZeneca Invests Big in Summit Therapeutics
- Sep 30, 2026 at 08:05 am
- OpenAI rolls out GPT-6.1 Sol, offering near-Astra performance at a fraction of the cost, alongside a new 'Ultrafast' speed tier. Meanwhile, AstraZeneca makes a significant $2 billion investment in oncology firm Summit Therapeutics.
-
-
































